SK419491A3 - Thf preparations - Google Patents

Thf preparations Download PDF

Info

Publication number
SK419491A3
SK419491A3 SK4194-91A SK419491A SK419491A3 SK 419491 A3 SK419491 A3 SK 419491A3 SK 419491 A SK419491 A SK 419491A SK 419491 A3 SK419491 A3 SK 419491A3
Authority
SK
Slovakia
Prior art keywords
thf
fractions
leu
amino acid
gamma
Prior art date
Application number
SK4194-91A
Other languages
English (en)
Slovak (sk)
Inventor
Nathan Trainin
Yigal Burstein
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of SK419491A3 publication Critical patent/SK419491A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/065—Thymic humoral factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK4194-91A 1985-06-06 1991-12-31 Thf preparations SK419491A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/741,753 US4621135A (en) 1983-12-08 1985-06-06 Novel THF compositions

Publications (1)

Publication Number Publication Date
SK419491A3 true SK419491A3 (en) 1995-07-11

Family

ID=24982034

Family Applications (1)

Application Number Title Priority Date Filing Date
SK4194-91A SK419491A3 (en) 1985-06-06 1991-12-31 Thf preparations

Country Status (16)

Country Link
US (1) US4621135A (de)
EP (1) EP0204328B1 (de)
JP (2) JPS6248698A (de)
KR (1) KR900003095B1 (de)
AT (1) ATE110389T1 (de)
AU (1) AU569193B2 (de)
CA (1) CA1270597A (de)
CZ (1) CZ419491A3 (de)
DE (2) DE204328T1 (de)
DK (1) DK262986A (de)
ES (6) ES8801322A1 (de)
HK (1) HK195495A (de)
IL (1) IL78951A (de)
NZ (1) NZ216316A (de)
SK (1) SK419491A3 (de)
ZA (1) ZA863848B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
MX339762B (es) * 2011-09-28 2016-05-27 Univ Autonoma Del Estado De Morelos Metalopeptidos inmunomoduladores (immp) y composiciones que los contienen.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4881838A (de) * 1972-02-15 1973-11-01
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
SE448605B (sv) * 1980-10-27 1987-03-09 Vtoroi Mo G Med I Imen Terapeutiskt preparat for reglering av t-immunsystemet och forfarande for framstellning derav
US4374828A (en) * 1980-11-17 1983-02-22 Board Of Reagents, The University Of Texas System Biologically active thymones from the thymus
IT1148005B (it) * 1981-04-09 1986-11-26 Leonida Grippa Tripeptide nelle sue sei combinazioni amminoacide alania fenilalanina e leucina in particolare fenil-alanina-alanina-leucina (p-a-l) aventela proprieta' di esaltare l'immunita' antivirale ed antitumorale
US4505898A (en) * 1982-04-21 1985-03-19 Marks Robert E Derivatives of acetylsalicylic acid and substituted phenylacetic acids and compositions containing them

Also Published As

Publication number Publication date
AU5833686A (en) 1987-01-08
DE3650035T2 (de) 1995-03-23
ES557736A0 (es) 1987-12-16
KR900003095B1 (ko) 1990-05-07
ES8801307A1 (es) 1987-12-16
IL78951A0 (en) 1986-09-30
DE204328T1 (de) 1987-11-05
CZ419491A3 (en) 1993-03-17
US4621135A (en) 1986-11-04
ZA863848B (en) 1987-12-30
AU569193B2 (en) 1988-01-21
ES8801322A1 (es) 1987-12-16
DK262986D0 (da) 1986-06-04
JPH0210160B2 (de) 1990-03-06
DE3650035D1 (de) 1994-09-29
JPH01156997A (ja) 1989-06-20
IL78951A (en) 1990-11-05
JPH0422919B2 (de) 1992-04-20
ES8801315A1 (es) 1987-12-16
ES8801317A1 (es) 1988-01-01
EP0204328A2 (de) 1986-12-10
ES8801308A1 (es) 1987-12-16
KR870000357A (ko) 1987-02-18
EP0204328A3 (en) 1988-07-27
ES557739A0 (es) 1988-01-01
EP0204328B1 (de) 1994-08-24
ES557738A0 (es) 1987-12-16
ATE110389T1 (de) 1994-09-15
DK262986A (da) 1986-12-07
JPS6248698A (ja) 1987-03-03
ES8801316A1 (es) 1987-12-16
CA1270597A (en) 1990-06-19
ES557737A0 (es) 1987-12-16
HK195495A (en) 1996-01-05
NZ216316A (en) 1991-11-26
ES555737A0 (es) 1987-12-16
ES557740A0 (es) 1987-12-16

Similar Documents

Publication Publication Date Title
Ling et al. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.
Mebs et al. Purification, properties and amino acid sequence of α-bungarotoxin from the venom of Bungarus multicinctus
Haritos et al. Parathymosin alpha: a peptide from rat tissues with structural homology to prothymosin alpha.
Reeve Jr et al. Amino acid sequences of three bombesin-like peptides from canine intestine extracts.
Kloczewiak et al. Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen γ chain
Anastasi et al. The isolation and amino acid sequence of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone
Stern et al. Opioid hexapeptides and heptapeptides in adrenal medulla and brain possible implications on the biosynthesis of enkephalins
Han et al. Studies on the Primary Structure of Bovine High-MolecularWeight Kininogen: Amino Acid Sequence of a Fragment (“Histidine-Rich Peptide”) Released by Plasma Kallikrein
Gurley et al. Proteins in the fossil bone of the dinosaur, Seismosaurus
van der Rest et al. A comprehensive approach to the study of collagen primary structure based on high‐performance liquid chromatography
Zhou et al. Unique cholecystokinin peptides isolated from guinea pig intestine
O'donnell et al. Amino acid sequence of a feather keratin from Silver Gull (Larus novae-hollandiae) and comparison with one from Emu (Dromaius novae-hollandiae)
Wendt et al. The Covalent Structure of Collagen: The Amino‐Acid Sequence of the 112‐Residues Amino‐Terminal Part of Peptide α1‐CB6 from Calf‐Skin Collagen
Gaus et al. Isolation and characterization of red-pigment-concentrating hormone (RPCH) from six crustacean species
Powers et al. Intrinsic photoaffinity labeling probes for cholecystokinin (CCK)-gastrin family receptors. D-Tyr-Gly-[Nle28, 31, pNO2-Phe33) CCK-26-33
Mitsuda et al. Purification of the 11 S component of soybean proteins
US4389343A (en) Immunopotentiating peptides from thymus
SK419491A3 (en) Thf preparations
Yuan et al. Microsequence analysis of peptides and proteins: I. Preparation of samples by reverse-phase liquid chromatography
Alpert Hydrophobic interaction chromatography of peptides as an alternative to reversed-phase chromatography
Bennett et al. α-N-acetyl-β-endorphin1–26 from the neurointermediary lobe of the rat pituitary: Isolation, purification, and characterization by high-performance liquid chromatography
Low et al. Solid-phase synthesis of thymosin. beta. 4: chemical and biological characterization of the synthetic peptide
Low et al. [16] Thymosin β4
Rosmus et al. Studies on the structure of collagen: I. The sequence analysis of peptides released by pronase
Kmiecik et al. Primary structure of histone H2A from nucleated erythrocyte of the marine worm Sipunculus nudus presence of two forms of H2A in the sipunculid chromatin